The clinical and genetic features of holocarboxylase synthetase deficiency in a male patient
10.3969/j.issn.1000-3606.2017.08.011
- VernacularTitle:全羧化酶合成酶缺乏症1例临床及基因分析
- Author:
Hong ZHENG
;
Tingting LU
;
Xiangpeng LU
;
Dongxiao LI
;
Bingxiang MA
;
Yanling YANG
- Keywords:
holocarboxylase synthetase deficiency;
HCS gene;
inherited metabolic diseases
- From:
Journal of Clinical Pediatrics
2017;35(8):605-608
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical, biochemical and genetic features of a Chinese boy with holocarboxylase synthetase deficiency (HCSD). Methods The clinical and genetic data of a rare case of HCSD were retrospectively analyzed. Results After birth, the boy showed development delay. At 3 months old, the boy was started with rehabilitation. Tandem mass spectrum and gas chromatography analysis was carried in the 5th month after birth because of the recurrent upper respiratory tract infection and elevated level of C5-OH in the blood and decreased level of C0,and elevated level of 3-OH-propionic, pyruvic acid, methylcrotonylglycine in the urine were in accordance with the HCSD. Genetic analysis found compound heterozygous mutations of c.1648G>A and c.1544G>A in gene, of which the latter one is novel. After the treatment of biotin (20 mg/d) and L-Carnitine, the condition of this boy was gradually improved. Conclutions HCSD is characterized with slow onset and inconspicuous manifestations. The confirmed diagnosis can be built with MS/MS, GC/MS analysis and gene mutation analysis. The effect of early biotin treatment is satisfactory. In this study,we carried out clinical and genetic diagnosis,which lays a solid foundation for prenatal diagnosis and early treatment.
